Literature DB >> 20214882

Leptin-derived peptide, a targeting ligand for mouse brain-derived endothelial cells via macropinocytosis.

Mina Tamaru1, Hidetaka Akita, Takahiro Fujiwara, Kazuaki Kajimoto, Hideyoshi Harashima.   

Abstract

Leptin is an appetite regulatory hormone that is secreted into the blood circulation by adipose tissue, and functions in the central nerve system (i.e. hypothalamus) by crossing the blood brain barrier (BBB). In the present study, we investigated the function of a leptin-derived peptide (Lep(70-89)) as a ligand for mouse brain-derived endothelial cells (MBEC4). Lep(70-89)-modified liposomes, prepared with a polyethyleneglycol (PEG) spacer (Lep(70-89)-PEG-LPs) exhibited a significantly higher cellular uptake than peptide-unmodified liposomes (PEG-LPs). Furthermore, cellular uptake was inhibited by amiloride, while no significant inhibitory effect was observed by the presence of chlorpromazine and filipin III, suggesting that macropinocytosis largely contributed to the cellular uptake of Lep(70-89)-PEG-LPs. Imaging studies revealed that Lep(70-89)-PEG-LPs were not colocalized with endosome/lysosomes, whereas neutral dextran (70 kDa) was predominantly colocalized with these compartments. This indicates that Lep(70-89)-PEG-LPs are taken up via macropinocytosis and are subject to non-classical intracellular trafficking, resulting in the circumvention of lysosomal degradation in endothelial cells. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20214882     DOI: 10.1016/j.bbrc.2010.03.024

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  9 in total

Review 1.  Promising approaches to circumvent the blood-brain barrier: progress, pitfalls and clinical prospects in brain cancer.

Authors:  Iason T Papademetriou; Tyrone Porter
Journal:  Ther Deliv       Date:  2015-08-25

Review 2.  In vitro models of the blood-brain barrier: An overview of commonly used brain endothelial cell culture models and guidelines for their use.

Authors:  Hans C Helms; N Joan Abbott; Malgorzata Burek; Romeo Cecchelli; Pierre-Olivier Couraud; Maria A Deli; Carola Förster; Hans J Galla; Ignacio A Romero; Eric V Shusta; Matthew J Stebbins; Elodie Vandenhaute; Babette Weksler; Birger Brodin
Journal:  J Cereb Blood Flow Metab       Date:  2016-02-11       Impact factor: 6.200

3.  Delivery of siRNA and other macromolecules into skin and cells using a peptide enhancer.

Authors:  Tracy Hsu; Samir Mitragotri
Journal:  Proc Natl Acad Sci U S A       Date:  2011-09-08       Impact factor: 11.205

4.  Targeting ischemic penumbra Part II: selective drug delivery using liposome technologies.

Authors:  Shimin Liu; Steven R Levine; H Richard Winn
Journal:  J Exp Stroke Transl Med       Date:  2011

5.  Topical delivery of siRNA into skin using SPACE-peptide carriers.

Authors:  Ming Chen; Michael Zakrewsky; Vivek Gupta; Aaron C Anselmo; Deborah H Slee; John A Muraski; Samir Mitragotri
Journal:  J Control Release       Date:  2014-01-13       Impact factor: 9.776

Review 6.  Crossing the Blood-Brain Barrier: Advances in Nanoparticle Technology for Drug Delivery in Neuro-Oncology.

Authors:  Andrew M Hersh; Safwan Alomari; Betty M Tyler
Journal:  Int J Mol Sci       Date:  2022-04-09       Impact factor: 6.208

Review 7.  Smuggling Drugs into the Brain: An Overview of Ligands Targeting Transcytosis for Drug Delivery across the Blood-Brain Barrier.

Authors:  Julia V Georgieva; Dick Hoekstra; Inge S Zuhorn
Journal:  Pharmaceutics       Date:  2014-11-17       Impact factor: 6.321

8.  Energy-Dependent Endocytosis Is Responsible for Skin Penetration of Formulations Based on a Combination of Indomethacin Nanoparticles and l-Menthol in Rat and Göttingen Minipig.

Authors:  Hiroko Otake; Mizuki Yamaguchi; Fumihiko Ogata; Saori Deguchi; Naoki Yamamoto; Hiroshi Sasaki; Naohito Kawasaki; Noriaki Nagai
Journal:  Int J Mol Sci       Date:  2021-05-12       Impact factor: 5.923

9.  Involvement of Endocytosis in the Transdermal Penetration Mechanism of Ketoprofen Nanoparticles.

Authors:  Noriaki Nagai; Fumihiko Ogata; Miyu Ishii; Yuya Fukuoka; Hiroko Otake; Yosuke Nakazawa; Naohito Kawasaki
Journal:  Int J Mol Sci       Date:  2018-07-23       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.